rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Clover Health Investments, Corp.

CLOV · Nasdaq

Health CareManaged Care & InsurersLeading

CLOV stood above a rising 150-day average in 23 of the last 52 weekly readings, including each of the last 23 weeks. It is 24.1% above that average now. Managed Care & Insurers: 80% of its 10 stocks in an uptrend (+10 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
23 in a row
Industry in uptrend
80% +10 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$15.4M
Officials’ trades on record
0
Institutions holding
214 (+21)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 23 of 52 weeks.

21 Apr – 20 Oct
23%55%87%Apr 26Jun 26Jul 26Sep 26Oct 26

Managed Care & Insurers: Most of its stocks are in an uptrend and the share has climbed sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$4.8M$0$849KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months42
Buyers · sellers0 · 8
WhoDidSharesTraded
Karen SoaresChief Legal Officersold19,275at $4.6620 Oct 2026filed 20 Oct 2026
Jamie L. ReynosoCEO, Medicare Advantagesold4,066at $4.4119 Oct 2026filed 20 Oct 2026
Jamie L. ReynosoCEO, Medicare Advantagesold18,273at $4.6815 Oct 2026filed 19 Oct 2026
Conrad WaiCEO, Counterpart Healthsold23,627at $4.6815 Oct 2026filed 19 Oct 2026
Joseph Clay ThorntonInterim CFOsold4,591at $4.6815 Oct 2026filed 19 Oct 2026
Karen SoaresChief Legal Officersold14,673at $4.6815 Oct 2026filed 19 Oct 2026
Andrew ToyChief Executive Officersold62,176at $4.6815 Oct 2026filed 19 Oct 2026
Jamie L. ReynosoCEO, Medicare Advantagesold2,006at $4.637 Oct 2026filed 7 Oct 2026
Jamie L. ReynosoCEO, Medicare Advantagesold8,750at $4.425 Oct 2026filed 5 Oct 2026
Andrew ToyChief Executive Officersold318,806at $4.191 Oct 2026filed 2 Oct 2026
Jamie L. ReynosoCEO, Medicare Advantagesold1,921at $4.5617 Sep 2026filed 18 Sep 2026
Joseph Frank OldakowskiVP OF FINANCE AND CONTROLLERsold3,170at $4.6416 Sep 2026filed 17 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders214+21 on the quarter
New · exited47 · 27
Reported value$782.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 202635,106,965$184.0M+3,266,453+10.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202618,037,661$94.5M+1,055,588+6.2%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202610,846,066$56.8M+790,556+7.9%
STATE STREET CORPadded · filed 7 Aug 202610,180,337$53.3M+620,448+6.5%
Nuveen, LLCadded · filed 11 Aug 20266,291,699$33.0M+5,356,156+572.5%
CHARLES SCHWAB INVESTMENT MANAGEMENT INCadded · filed 14 Aug 20265,521,188$28.9M+220,713+4.2%
Sixth Street Partners Management Company, L.P.new · filed 14 Aug 20265,521,188$28.9M+5,521,188
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 20264,470,452$23.4M+774,015+20.9%
NORTHERN TRUST CORPadded · filed 13 Aug 20263,772,600$19.8M+466,025+14.1%
PNC Financial Services Group, Inc.reduced · filed 7 Aug 20263,563,874$18.7M-200,160−5.3%
31 Mar 2023 – 30 Jun 2026
123167211Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Karen Soares Company insiderChief Legal Officer · last 20 Oct 20260 · 7
Jamie L. Reynoso Company insiderCEO, Medicare Advantage · last 19 Oct 20260 · 25
Andrew Toy Company insiderChief Executive Officer · last 15 Oct 20260 · 5
Conrad Wai Company insiderCEO, Counterpart Health · last 15 Oct 20260 · 7
Joseph Clay Thornton Company insiderInterim CFO · last 15 Oct 20260 · 3
Brian James Miller Company insiderDirector · last 30 Sep 20260 · 0
Robert G. Torricelli Company insiderDirector · last 30 Sep 20260 · 0
Joseph Frank Oldakowski Company insiderVP OF FINANCE AND CONTROLLER · last 16 Sep 20260 · 3
Carladenise Armbrister Edwards Company insiderDirector · last 18 May 20260 · 2
Brady Patrick Priest Company insiderCEO of Clover Care Services · last 13 May 20260 · 3
Peter J. Kuipers Company insiderChief Financial Officer · last 29 Jan 20260 · 0
Vivek Garipalli Company insiderDirector, 10% owner · last 7 Jan 20264 · 0

Same industry

HUM HumanaLeading+28%
CNC CenteneLeading+21%
MOH Molina HealthcareJust started moving+15%
UNH UnitedHealth GroupJust started moving+11%
CI The Cigna GroupJust started moving+9%
TRUP TrupanionAbove a falling average+12%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-4.4%
Free cash flow marginFY 2025 · to 31 Dec 2025-3.6%
Return on capital employedFY 2025 · to 31 Dec 2025-25.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$78.3M
Free cash flowFY 2025 · to 31 Dec 2025−$69.0M

Analyst forecasts

No analyst forecasts yet.